Skip to main content

Office of Clinical Trials

Current COVID-19 information can be found on the OVCR, OHRE, and CRSO websites.

The core purpose of the Office of Clinical Trials (OCT) is to ensure compliance with federal, state and institutional requirements.

  • Supporting the Human Research Protection Program by conducting post IRB approval reviews of clinical studies through the Clinical Trials Quality Assurance (CTQA) program
  • Ensure correct clinical trial billing of research subjects through the Research Billing Compliance Program
  • Ensure compliance with the ClinicalTrials.gov registration results reporting
  • Ensure compliance by reviewing the billing coverage analysis, fully executed agreement and IRB approved consent form for congruency and accuracy
  • Coordinate the Scientific Review Committee and serve as a resource for protocol development for the research community
  • Serving as the point of contact for questions or issues related to clinical trials
  • Developing and implementing programs and initiatives to enhance the quality of clinical research and support regulatory compliance, through the implementation of the OnCore clinical trials management system enterprise wide
  • Our office is available for education, consultation and guidance on the conduct of clinical trials

OCT Policies and Procedures

OCT Staff and Contact Information